{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:21:45Z","timestamp":1782156105425,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Scientific Research Foundation of Anqing Municipal government","award":["2022Z2001"],"award-info":[{"award-number":["2022Z2001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To further evaluate the causal relationships between inflammatory cytokines and migraine, we conducted a bidirectional, two-sample Mendelian randomization (MR) analysis using genetic data from publicly available genome-wide association studies (GWAS). We used several MR methods, including random-effect inverse-variance weighting (IVW), weighted median, MR-Egger, to test the causal relationships. Sensitivity analyses were also conducted to evaluate the robustness of the results. The results showed that hepatocyte growth factor (HGF) was positively associated with the risk of migraine (odds ratio [OR], 1.004; 95% confidence interval [CI], 1.001\u20131.008; P\u2009=\u20090.022). In addition, Interleukin-2 (IL-2) was considered a downstream consequence of migraine (OR, 0.012; 95% CI, 0.000\u20130.0929; P\u2009=\u20090.046). These findings suggest that HGF may be a factor associated with the etiology of migraine, while IL-2 is more likely to be involved in the downstream development of migraine.<\/jats:p>","DOI":"10.1038\/s41598-023-46797-3","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T13:02:34Z","timestamp":1699448554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring the causal relationship between inflammatory cytokines and migraine: a bidirectional, two-sample Mendelian randomization study"],"prefix":"10.1038","volume":"13","author":[{"given":"Chong","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"46797_CR1","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina, M. et al. Migraine: Disease characterisation, biomarkers, and precision medicine. The Lancet 397, 1496\u20131504 (2021).","journal-title":"The Lancet"},{"key":"46797_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin, V. L. et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459\u2013480 (2019).","journal-title":"Lancet Neurol."},{"key":"46797_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner, T. J., Stovner, L. J., Vos, T., Jensen, R. & Katsarava, Z. Migraine is first cause of disability in under 50s: Will health politicians now take notice?. J. Headache Pain 19, 1\u20134 (2018).","journal-title":"J. Headache Pain"},{"key":"46797_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jnnp-2021-327992","volume":"93","author":"S de-Vries-Lentsch","year":"2022","unstructured":"de-Vries-Lentsch, S., Al-Hassany, L., Ferrari, M. D., Terwindt, G. M. & Maassen-VanDen-Brink, A. CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab. J. Neurol. Neurosurg. Psychiatry 93, 911\u2013912 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"46797_CR5","doi-asserted-by":"publisher","first-page":"111557","DOI":"10.1016\/j.biopha.2021.111557","volume":"139","author":"J Khan","year":"2021","unstructured":"Khan, J. et al. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed. Pharmacother. 139, 111557 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"46797_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1371\/journal.pone.0045295","volume":"7","author":"J Pakpoor","year":"2012","unstructured":"Pakpoor, J., Handel, A. E., Giovannoni, G., Dobson, R. & Ramagopalan, S. V. Meta-analysis of the relationship between multiple sclerosis and migraine. Plos One 7, 598 (2012).","journal-title":"Plos One"},{"key":"46797_CR7","first-page":"748","volume":"14","author":"H Olfati","year":"2023","unstructured":"Olfati, H., Mirmosayyeb, O., Hosseinabadi, A. M. & Ghajarzadeh, M. The prevalence of migraine in inflammatory bowel disease, a systematic review and meta-analysis. Int. J. Prevent. Med. 14, 748 (2023).","journal-title":"Int. J. Prevent. Med."},{"key":"46797_CR8","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/jcm9061890","volume":"9","author":"S Mathieu","year":"2020","unstructured":"Mathieu, S. et al. Prevalence of migraine and neuropathic pain in rheumatic diseases. J. Clin. Med. 9, 1890 (2020).","journal-title":"J. Clin. Med."},{"key":"46797_CR9","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3390\/microorganisms11082083","volume":"11","author":"\u00c1 Kapp\u00e9ter","year":"2023","unstructured":"Kapp\u00e9ter, \u00c1. et al. Migraine as a disease associated with dysbiosis and possible therapy with fecal microbiota transplantation. Microorganisms 11, 2083 (2023).","journal-title":"Microorganisms"},{"key":"46797_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1526-4637.2009.00791.x","volume":"11","author":"IA Y\u0131lmaz","year":"2010","unstructured":"Y\u0131lmaz, I. A. et al. Cytokine polymorphism in patients with migraine: Some suggestive clues of migraine and inflammation. Pain Med. 11, 492\u2013497 (2010).","journal-title":"Pain Med."},{"key":"46797_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s13760-020-01362-x","volume":"121","author":"G Sar\u0131cam","year":"2021","unstructured":"Sar\u0131cam, G. Relationship between migraine headache and hematological parameters. Acta Neurol. Belg. 121, 899\u2013905 (2021).","journal-title":"Acta Neurol. Belg."},{"key":"46797_CR12","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1161\/STROKEAHA.120.029902","volume":"51","author":"OE Titova","year":"2020","unstructured":"Titova, O. E., Micha\u00eblsson, K. & Larsson, S. C. Sleep duration and stroke: Prospective cohort study and Mendelian randomization analysis. Stroke 51, 3279\u20133285 (2020).","journal-title":"Stroke"},{"key":"46797_CR13","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/s41366-021-00942-y","volume":"45","author":"M Ahmed","year":"2021","unstructured":"Ahmed, M. et al. Adiposity and cancer: A Mendelian randomization analysis in the UK biobank. Int. J. Obes. 45, 2657\u20132665 (2021).","journal-title":"Int. J. Obes."},{"key":"46797_CR14","first-page":"748","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Smith, G. D. Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ 362, 748 (2018).","journal-title":"BMJ"},{"key":"46797_CR15","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey-Smith","year":"2014","unstructured":"Davey-Smith, G. & Hemani, G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89\u2013R98 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"46797_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/oby.23060","volume":"29","author":"M Kalaoja","year":"2021","unstructured":"Kalaoja, M. et al. The role of inflammatory cytokines as intermediates in the pathway from increased adiposity to disease. Obesity 29, 428\u2013437 (2021).","journal-title":"Obesity"},{"key":"46797_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1468-2982.2005.01021.x","volume":"26","author":"A \u00d6zge","year":"2006","unstructured":"\u00d6zge, A. et al. The relationship between migraine and atopic disorders\u2014the contribution of pulmonary function tests and immunological screening. Cephalalgia 26, 172\u2013179 (2006).","journal-title":"Cephalalgia"},{"key":"46797_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/cei\/uxab025","volume":"207","author":"L Biscetti","year":"2022","unstructured":"Biscetti, L. et al. Immunological findings in patients with migraine and other primary headaches: A narrative review. Clin. Exp. Immunol. 207, 11\u201326 (2022).","journal-title":"Clin. Exp. Immunol."},{"key":"46797_CR19","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1007\/s10072-021-05429-2","volume":"42","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z., Zhao, L. & Li, T. Additional large-scale studies are needed to clarify the relationship between TNF\u03b1 gene and migraine risk. Neurol. Sci. 42, 4333\u20134334 (2021).","journal-title":"Neurol. Sci."},{"key":"46797_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0333102415625614","volume":"37","author":"RM van Dongen","year":"2017","unstructured":"van Dongen, R. M. et al. Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis. Cephalalgia 37, 49\u201363 (2017).","journal-title":"Cephalalgia"},{"key":"46797_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1350-9462(00)00015-X","volume":"19","author":"I Grierson","year":"2000","unstructured":"Grierson, I. et al. Hepatocyte growth factor\/scatter factor in the eye. Progress Retinal Eye Res. 19, 779\u2013802 (2000).","journal-title":"Progress Retinal Eye Res."},{"key":"46797_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/oxfordjournals.jbchem.a021283","volume":"119","author":"K Matsumoto","year":"1996","unstructured":"Matsumoto, K. & Nakamura, T. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. 119, 591\u2013600 (1996).","journal-title":"J. Biochem."},{"key":"46797_CR23","doi-asserted-by":"publisher","first-page":"683609","DOI":"10.3389\/fcell.2021.683609","volume":"9","author":"C Desole","year":"2021","unstructured":"Desole, C. et al. HGF and MET: From brain development to neurological disorders. Front. Cell Dev. Biol. 9, 683609 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"46797_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejso.2006.10.036","volume":"33","author":"C-Y Hsia","year":"2007","unstructured":"Hsia, C.-Y. et al. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Eur. J. Surg. Oncol. (EJSO) 33, 208\u2013212 (2007).","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"46797_CR25","doi-asserted-by":"publisher","first-page":"12414","DOI":"10.1523\/JNEUROSCI.3135-10.2010","volume":"30","author":"E Gascon","year":"2010","unstructured":"Gascon, E. et al. Hepatocyte growth factor-Met signaling is required for Runx1 extinction and peptidergic differentiation in primary nociceptive neurons. J. Neurosci. 30, 12414\u201312423 (2010).","journal-title":"J. Neurosci."},{"key":"46797_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","volume":"26","author":"TR Malek","year":"2008","unstructured":"Malek, T. R. The biology of interleukin-2. Annu. Rev. Immunol. 26, 453\u2013479 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"46797_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","volume":"78","author":"M Rosenzwajg","year":"2019","unstructured":"Rosenzwajg, M. et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann. Rheum. Dis. 78, 209\u2013217 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"46797_CR28","doi-asserted-by":"publisher","first-page":"17045","DOI":"10.1073\/pnas.1902091116","volume":"116","author":"R Fischer","year":"2019","unstructured":"Fischer, R. et al. TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes. Proc. Natl. Acad. Sci. 116, 17045\u201317050 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"46797_CR29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1097\/j.pain.0000000000001818","volume":"161","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders. Pain 161, 1381 (2020).","journal-title":"Pain"},{"key":"46797_CR30","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.1007\/s11033-020-05781-0","volume":"47","author":"S P\u00e9rez-Pereda","year":"2020","unstructured":"P\u00e9rez-Pereda, S. et al. Serum CGRP, VIP, and PACAP usefulness in migraine: A case\u2013control study in chronic migraine patients in real clinical practice. Mol. Biol. Rep. 47, 7125\u20137138 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"46797_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/apha.12427","volume":"213","author":"D Ganea","year":"2015","unstructured":"Ganea, D., Hooper, K. M. & Kong, W. The neuropeptide vasoactive intestinal peptide: Direct effects on immune cells and involvement in inflammatory and autoimmune diseases. Acta Physiol. 213, 442\u2013452 (2015).","journal-title":"Acta Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46797-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46797-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46797-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T13:08:39Z","timestamp":1699448919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46797-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46797"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46797-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19394"}}